Randomized trials of prostate cancer screening.
作者信息
Loeb Stacy, Partin Alan W
机构信息
The James Buchanan Brady Urological Institute, Department of Urology, The Johns Hopkins Medical Institutions Baltimore, MD.
出版信息
Rev Urol. 2009 Summer;11(3):179-80.
Abstract
摘要
相似文献
1
Randomized trials of prostate cancer screening.前列腺癌筛查的随机试验。
Rev Urol. 2009 Summer;11(3):179-80.
2
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.大规模随机前列腺癌筛查试验：欧洲前列腺癌随机筛查试验和前列腺、肺、结直肠癌和卵巢癌试验中的项目表现
Int J Cancer. 2002 Jan 10;97(2):237-44. doi: 10.1002/ijc.1588.
5
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.用前列腺特异性抗原检测进行前列腺癌筛查：当前证据回顾。
JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085.
6
Randomized trial results did not resolve controversies surrounding prostate cancer screening.随机试验结果并未解决围绕前列腺癌筛查的争议。
Curr Opin Urol. 2010 May;20(3):189-93. doi: 10.1097/MOU.0b013e3283383b55.
7
Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.前列腺癌筛查：欧洲随机前列腺癌筛查研究（ERSPC）和前列腺、肺癌、结直肠癌和卵巢癌筛查试验（PLCO）综述
Rev Urol. 2009 Summer;11(3):127-33.
8
Screening for prostate cancer.前列腺癌筛查
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004720. doi: 10.1002/14651858.CD004720.pub2.
9
Screening for prostate cancer: a Cochrane systematic review.前列腺癌筛查：一项Cochrane系统评价
Cancer Causes Control. 2007 Apr;18(3):279-85. doi: 10.1007/s10552-006-0087-6. Epub 2007 Jan 6.
引用本文的文献
1
Update of randomized trials for prostate cancer screening.前列腺癌筛查随机试验的最新情况。
Rev Urol. 2013;15(1):37-9.
2
What is the true mortality benefit of prostate-specific antigen screening?前列腺特异性抗原筛查的真正死亡率益处是什么？
Rev Urol. 2010 Winter;12(1):66-7.
本文引用的文献
1
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
2
Mortality results from a randomized prostate-cancer screening trial.一项前列腺癌随机筛查试验的死亡率结果。
N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18.
3
Screening for prostate cancer--the controversy that refuses to die.前列腺癌筛查——经久不息的争议。
N Engl J Med. 2009 Mar 26;360(13):1351-4. doi: 10.1056/NEJMe0901166. Epub 2009 Mar 18.
4
Screening for breast cancer with mammography.通过乳房X线摄影术筛查乳腺癌。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001877. doi: 10.1002/14651858.CD001877.pub2.
5
Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam.在荷兰鹿特丹前列腺癌筛查试验（ERSPC）中，相隔四年的两轮后续筛查中的肿瘤特征及预后因素。
Urology. 2006 Sep;68(3):615-20. doi: 10.1016/j.urology.2006.03.015.
6
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial.前列腺癌筛查可降低被诊断为晚期前列腺癌的绝对风险——一项基于人群的前瞻性随机对照试验的结果
Eur Urol. 2007 Mar;51(3):659-64. doi: 10.1016/j.eururo.2006.07.012. Epub 2006 Jul 28.
7
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.在前列腺、肺、结肠直肠和卵巢癌筛查试验中筛查结果呈阳性后进行前列腺活检。
J Urol. 2005 Mar;173(3):746-50; discussion 750-1. doi: 10.1097/01.ju.0000152697.25708.71.
8
Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites.男性是否知道他们做过前列腺特异性抗原检测？两个地点检测自我报告的准确性。
Am J Public Health. 2004 Aug;94(8):1336-8. doi: 10.2105/ajph.94.8.1336.
9
Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?在美国对男性进行前列腺癌和结直肠癌筛查：实际做法是否符合证据？
JAMA. 2003 Mar 19;289(11):1414-20. doi: 10.1001/jama.289.11.1414.
10
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.前列腺、肺、结肠直肠和卵巢（PLCO）癌筛查试验的设计。
Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S. doi: 10.1016/s0197-2456(00)00098-2.
Zotero 插件